ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "63126674-b8e9-4191-b1c0-5e92e0f3efc8"}, "_deposit": {"id": "2016095", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "2016095"}, "status": "published"}, "_oai": {"id": "oai:u-ryukyu.repo.nii.ac.jp:02016095", "sets": ["1642838214651", "1642838412624"]}, "author_link": [], "item_1617186331708": {"attribute_name": "Title", "attribute_value_mlt": [{"subitem_1551255647225": "[原著]再発乳癌に対する治療成績とその予後についての検討", "subitem_1551255648112": "ja"}, {"subitem_1551255647225": "Chemoendocrine therapy for patients with recurrence of breast cancer and its outcome", "subitem_1551255648112": "en"}]}, "item_1617186419668": {"attribute_name": "Creator", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "久高, 学", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "久高, 弘志", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "与儀, 実津夫", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "稲福, 行夫", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "川野, 幸志", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "山城, 和也", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "大城, 健誠", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "照屋, 剛", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "比嘉, 宇郎", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "平良, 勝己", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "豊見山, 健", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "砂川, 宏樹", "creatorNameLang": "ja"}]}]}, "item_1617186476635": {"attribute_name": "Access Rights", "attribute_value_mlt": [{"subitem_1522299639480": "open access", "subitem_1600958577026": "http://purl.org/coar/access_right/c_abf2"}]}, "item_1617186499011": {"attribute_name": "Rights", "attribute_value_mlt": [{"subitem_1522650717957": "ja", "subitem_1522651041219": "琉球医学会"}]}, "item_1617186609386": {"attribute_name": "Subject", "attribute_value_mlt": [{"subitem_1522299896455": "en", "subitem_1522300014469": "Other", "subitem_1523261968819": "breast cancer"}, {"subitem_1522299896455": "en", "subitem_1522300014469": "Other", "subitem_1523261968819": "recurrence"}, {"subitem_1522299896455": "en", "subitem_1522300014469": "Other", "subitem_1523261968819": "metastasis"}]}, "item_1617186626617": {"attribute_name": "Description", "attribute_value_mlt": [{"subitem_description": "This study was to investigate retrospectively patients with recurrence of breast cancer to clarify relationship between tumor characteristics at the time of initial surgery and outcome by chemoendocrine treatment strategies. We examined 299 patients with primary breast cancer in our institution between 1987 and 1999. Of these, there were 39 patients (13.0% of all) who developed recurrence. The initial sites of recurrence were skin (17.9% of all recurrence), lymphnodes (25.6%), bone (35.9%), lung/pleura (23.1%), and liver (17.9%). The incidence of recurrence was more frequent in patients with scirrhous carcinomas than in patients with papillotubular carcinomas. Factors of t (p\u003c 0.01), n (p\u003c 0.01), ly (p\u003c 0.01) and macroscopic extension (p\u003c 0.01) at the time of initial surgery were significant predictors for recurrence. Patients with bone or local metastasis were treated with chemoendocnne therapy consisting of cyclophosphamide, 5\u0027-DFUR and medroxyprogesterone acetate with luteimzing hormone-releasing hormone agonist for premenopausal women and aromatase inhibitor for postmenopausal women. Patients with lung or liver metastasis were treated with CEF(cyclophosphamide/epirubicin/5-FU) and endocrine therapy. The overall response rate for this chemoendocrine therapy was 38.0% (complete remission, 9.5%, partial remission, 28.6%  and the 5-year survival rate was 9.4%. The patients with liver metastasis had poorer prognosis.", "subitem_description_type": "Other"}, {"subitem_description": "論文", "subitem_description_type": "Other"}]}, "item_1617186643794": {"attribute_name": "Publisher", "attribute_value_mlt": [{"subitem_1522300295150": "ja", "subitem_1522300316516": "琉球医学会"}, {"subitem_1522300295150": "en", "subitem_1522300316516": "Ryukyu Medical Association"}]}, "item_1617186702042": {"attribute_name": "Language", "attribute_value_mlt": [{"subitem_1551255818386": "jpn"}]}, "item_1617186920753": {"attribute_name": "Source Identifier", "attribute_value_mlt": [{"subitem_1522646500366": "ISSN", "subitem_1522646572813": "1346888X"}, {"subitem_1522646500366": "ISSN", "subitem_1522646572813": "0289-1530"}, {"subitem_1522646500366": "NCID", "subitem_1522646572813": "AN10369445"}]}, "item_1617186941041": {"attribute_name": "Source Title", "attribute_value_mlt": [{"subitem_1522650068558": "ja", "subitem_1522650091861": "琉球医学会誌 = Ryukyu Medical Journal"}]}, "item_1617187056579": {"attribute_name": "Bibliographic Information", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1999", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "4", "bibliographicPageEnd": "233", "bibliographicPageStart": "229", "bibliographicVolumeNumber": "19"}]}, "item_1617258105262": {"attribute_name": "Resource Type", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_1617265215918": {"attribute_name": "Version Type", "attribute_value_mlt": [{"subitem_1522305645492": "VoR", "subitem_1600292170262": "http://purl.org/coar/version/c_970fb48d4fbd8a85"}]}, "item_1617605131499": {"attribute_name": "File", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_access", "download_preview_message": "", "file_order": 0, "filename": "v19p229.pdf", "future_date_message": "", "is_thumbnail": false, "mimetype": "", "size": 0, "url": {"objectType": "fulltext", "url": "https://u-ryukyu.repo.nii.ac.jp/record/2016095/files/v19p229.pdf"}, "version_id": "f2dc3f08-ef00-4e61-a0f3-b5acb5225c09"}]}, "item_title": "[原著]再発乳癌に対する治療成績とその予後についての検討", "item_type_id": "15", "owner": "1", "path": ["1642838214651", "1642838412624"], "permalink_uri": "http://hdl.handle.net/20.500.12000/0002016095", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2010-07-02"}, "publish_date": "2010-07-02", "publish_status": "0", "recid": "2016095", "relation": {}, "relation_version_is_last": true, "title": ["[原著]再発乳癌に対する治療成績とその予後についての検討"], "weko_shared_id": -1}
  1. 学術雑誌論文
  2. 琉球医学会
  3. 琉球医学会誌
  4. 19巻4号
  1. 部局別インデックス
  2. その他

[原著]再発乳癌に対する治療成績とその予後についての検討

http://hdl.handle.net/20.500.12000/0002016095
http://hdl.handle.net/20.500.12000/0002016095
fe02db06-d8ab-408e-87b2-70615471e04d
名前 / ファイル ライセンス アクション
v19p229.pdf v19p229.pdf
Item type デフォルトアイテムタイプ(フル)(1)
公開日 2010-07-02
タイトル
タイトル [原著]再発乳癌に対する治療成績とその予後についての検討
言語 ja
タイトル
タイトル Chemoendocrine therapy for patients with recurrence of breast cancer and its outcome
言語 en
作成者 久高, 学

× 久高, 学

ja 久高, 学

Search repository
久高, 弘志

× 久高, 弘志

ja 久高, 弘志

Search repository
与儀, 実津夫

× 与儀, 実津夫

ja 与儀, 実津夫

Search repository
稲福, 行夫

× 稲福, 行夫

ja 稲福, 行夫

Search repository
川野, 幸志

× 川野, 幸志

ja 川野, 幸志

Search repository
山城, 和也

× 山城, 和也

ja 山城, 和也

Search repository
大城, 健誠

× 大城, 健誠

ja 大城, 健誠

Search repository
照屋, 剛

× 照屋, 剛

ja 照屋, 剛

Search repository
比嘉, 宇郎

× 比嘉, 宇郎

ja 比嘉, 宇郎

Search repository
平良, 勝己

× 平良, 勝己

ja 平良, 勝己

Search repository
豊見山, 健

× 豊見山, 健

ja 豊見山, 健

Search repository
砂川, 宏樹

× 砂川, 宏樹

ja 砂川, 宏樹

Search repository
アクセス権
アクセス権 open access
アクセス権URI http://purl.org/coar/access_right/c_abf2
権利情報
言語 ja
権利情報 琉球医学会
主題
言語 en
主題Scheme Other
主題 breast cancer
主題
言語 en
主題Scheme Other
主題 recurrence
主題
言語 en
主題Scheme Other
主題 metastasis
内容記述
内容記述タイプ Other
内容記述 This study was to investigate retrospectively patients with recurrence of breast cancer to clarify relationship between tumor characteristics at the time of initial surgery and outcome by chemoendocrine treatment strategies. We examined 299 patients with primary breast cancer in our institution between 1987 and 1999. Of these, there were 39 patients (13.0% of all) who developed recurrence. The initial sites of recurrence were skin (17.9% of all recurrence), lymphnodes (25.6%), bone (35.9%), lung/pleura (23.1%), and liver (17.9%). The incidence of recurrence was more frequent in patients with scirrhous carcinomas than in patients with papillotubular carcinomas. Factors of t (p< 0.01), n (p< 0.01), ly (p< 0.01) and macroscopic extension (p< 0.01) at the time of initial surgery were significant predictors for recurrence. Patients with bone or local metastasis were treated with chemoendocnne therapy consisting of cyclophosphamide, 5'-DFUR and medroxyprogesterone acetate with luteimzing hormone-releasing hormone agonist for premenopausal women and aromatase inhibitor for postmenopausal women. Patients with lung or liver metastasis were treated with CEF(cyclophosphamide/epirubicin/5-FU) and endocrine therapy. The overall response rate for this chemoendocrine therapy was 38.0% (complete remission, 9.5%, partial remission, 28.6% and the 5-year survival rate was 9.4%. The patients with liver metastasis had poorer prognosis.
内容記述
内容記述タイプ Other
内容記述 論文
出版者
言語 ja
出版者 琉球医学会
出版者
言語 en
出版者 Ryukyu Medical Association
言語
言語 jpn
資源タイプ
資源タイプ journal article
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
収録物識別子
収録物識別子タイプ ISSN
収録物識別子 1346888X
収録物識別子
収録物識別子タイプ ISSN
収録物識別子 0289-1530
収録物識別子
収録物識別子タイプ NCID
収録物識別子 AN10369445
収録物名
言語 ja
収録物名 琉球医学会誌 = Ryukyu Medical Journal
書誌情報
巻 19, 号 4, p. 229-233, 発行日 1999
戻る
0
views
See details
Views

Versions

Ver.1 2022-02-22 04:13:43.655217
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3